Call averages and coverage percentages tell you how busy a field force is. They tell you almost nothing about whether prescriptions are actually moving. The gap is HCP-level prescription intelligence: who is prescribing, who is switching, who is wavering, and what was said in the last conversation that explains it.
Fragmented records, lost context
When visit notes live in one app, Rx data in another and engagement history in a manager's memory, every call starts cold. Reps lose the thread of objections raised last month; managers cannot see switching risk building in a key account until the numbers drop.
Track intent, not just activity
A prescription-intent score per HCP, updated from each visit, changes the conversation from "did we call?" to "are they converting?" Layer in objection patterns and competitor mentions and you have a coaching signal, not just a CRM record.
Territory-level patterns
Aggregate those signals and switching risk, product traction and white-space become visible at territory level, exactly where managers allocate effort. That is how field investment connects to prescription outcomes instead of disappearing into activity metrics.
Pharos RxFlow in practice
Pharos RxFlow gives reps and managers a structured view of HCP-level Rx activity, engagement history and AI post-visit call analysis, built for relationship-driven prescription growth and connected to the rest of the Pharos commercial suite.
Ready to apply this thinking?
Start a pilot project and evaluate Ichelon's quality within one delivery cycle.